Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Boon For Lupin As FDA Upgrades Somerset Site Status
Stricken US Facility Handed Voluntary Action Indicated Status By FDA
Jul 11 2022
•
By
Dean Rudge
Lupin must return its facilities to FDA compliance • Source: Shutterstock
More from Manufacturing
More from Business